Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al

Ann Surg Oncol. 2021 Jun;28(6):3433-3434. doi: 10.1245/s10434-020-09258-z. Epub 2020 Oct 26.

Authors

Marcus Eby¹, Christopher W Seder²

Affiliations

¹ Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.
² Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA. christopher_w_seder@rush.edu.

PMID: 33106974
DOI: 10.1245/s10434-020-09258-z

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / surgery
Combined Modality Therapy
Humans
Lung Neoplasms* / therapy
Surgical Oncology*